Huilai Lv

407 total citations
27 papers, 240 citations indexed

About

Huilai Lv is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Huilai Lv has authored 27 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Huilai Lv's work include Esophageal Cancer Research and Treatment (13 papers), Gastric Cancer Management and Outcomes (10 papers) and RNA modifications and cancer (8 papers). Huilai Lv is often cited by papers focused on Esophageal Cancer Research and Treatment (13 papers), Gastric Cancer Management and Outcomes (10 papers) and RNA modifications and cancer (8 papers). Huilai Lv collaborates with scholars based in China. Huilai Lv's co-authors include Yuefeng Zhang, Yanzhao Xu, Ming‐Bo Wang, Chao‐Yuan Huang, Yonggang Zhu, Lianmei Zhao, Jiachen Li, Fan Zhang, Peng Su and Guiying Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Huilai Lv

24 papers receiving 236 citations

Peers

Huilai Lv
Isabela W. Cunha Brazil
Yang Cheng China
C Meregalli Italy
Zixin Guo China
Masataka Shimonosono Japan
Ling‐Yu Chu China
Xingcheng Wu China
Annalise Katz‐Summercorn United Kingdom
Kunli Du China
Junhui Fu China
Isabela W. Cunha Brazil
Huilai Lv
Citations per year, relative to Huilai Lv Huilai Lv (= 1×) peers Isabela W. Cunha

Countries citing papers authored by Huilai Lv

Since Specialization
Citations

This map shows the geographic impact of Huilai Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huilai Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huilai Lv more than expected).

Fields of papers citing papers by Huilai Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huilai Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huilai Lv. The network helps show where Huilai Lv may publish in the future.

Co-authorship network of co-authors of Huilai Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Huilai Lv. A scholar is included among the top collaborators of Huilai Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huilai Lv. Huilai Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Jinyang, Yanzhao Xu, Chao‐Yuan Huang, et al.. (2024). Oblique conformal anastomosis decreased the risks of cervical anastomotic leakage after totally minimally invasive esophagectomy. Asian Journal of Surgery. 47(8). 3478–3484.
2.
Lv, Huilai, et al.. (2024). Survival outcomes of neoadjuvant immunochemotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology. 150(5). 260–260. 1 indexed citations
3.
Wei, Sisi, Cong Zhang, Lei Li, et al.. (2024). Periplcymarin targets glycolysis and mitochondrial oxidative phosphorylation of esophageal squamous cell carcinoma: Implication in anti-cancer therapy. Phytomedicine. 128. 155539–155539. 7 indexed citations
4.
Wei, Sisi, Xinyi Fan, Xiaoya Li, et al.. (2024). Hypoxia Induced Lnc191 Upregulation Dictates the Progression of Esophageal Squamous Cell Carcinoma by Activating GRP78/ERK Pathway. Advanced Science. 12(4). e2406674–e2406674.
5.
Wang, Yaojie, Sisi Wei, Suli Dai, et al.. (2024). NEK2 Promotes ESCC Malignant Progression by Inhibiting Cellular Senescence via the FOXM1/c‐Myc/p27 Signaling Pathway. Molecular Carcinogenesis. 64(2). 244–259. 1 indexed citations
6.
Lv, Huilai, Chao‐Yuan Huang, Jiachen Li, et al.. (2023). The survival outcomes of neoadjuvant sintilimab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma. Frontiers in Immunology. 13. 1100750–1100750. 15 indexed citations
7.
Lv, Huilai, et al.. (2023). Prediction model using risk factors associated with anastomotic leakage after minimally invasive esophagectomy. Pakistan Journal of Medical Sciences. 39(5). 1345–1349. 4 indexed citations
8.
Wang, Yaojie, Zhi Li, Sisi Wei, et al.. (2023). Combination of size‐exclusion chromatography and ion exchange adsorption for improving the proteomic analysis of plasma‐derived extracellular vesicles. PROTEOMICS. 23(9). e2200364–e2200364. 12 indexed citations
9.
Lv, Huilai, et al.. (2022). hsa_circ_0000518 Facilitates Non-Small-Cell Lung Cancer Progression via Moderating miR-330-3p and Positively Regulating SLC1A5. Journal of Immunology Research. 2022. 1–19. 8 indexed citations
10.
Lv, Huilai, et al.. (2022). Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 12. 864533–864533. 18 indexed citations
11.
12.
13.
14.
Xu, Yanzhao, et al.. (2021). Epigenetic Study of Esophageal Carcinoma Based on Methylation, Gene Integration and Weighted Correlation Network Analysis. OncoTargets and Therapy. Volume 14. 3133–3149. 10 indexed citations
15.
Lv, Huilai, et al.. (2021). 557 Neoadjuvant Camrelizumab in combination with albumin paclitaxel and cisplatin for patients with locally advanced esophageal squamous cell carcinoma (ESCC). Regular and Young Investigator Award Abstracts. A587–A587. 2 indexed citations
16.
Yang, Fei, Yuefeng Zhang, Yanzhao Xu, et al.. (2019). Identifying potential metastasis‐related long non‐coding RNAs, microRNAs, and message RNAs in the esophageal squamous cell carcinoma. Journal of Cellular Biochemistry. 120(8). 13202–13215. 15 indexed citations
17.
Zhang, Yuefeng, Yanzhao Xu, Zhenhua Li, et al.. (2018). Identification of the key transcription factors in esophageal squamous cell carcinoma. Journal of Thoracic Disease. 10(1). 148–161. 30 indexed citations
18.
Jia, Yan, Lianmei Zhao, Cong Zhang, et al.. (2018). The tumor-suppressive function of miR-1296-5p by targeting EGFR and CDK6 in gastric cancer. Bioscience Reports. 39(1). 22 indexed citations
19.
Zhang, Yuefeng, et al.. (2017). Identification of dysregulated long non-coding RNAs/microRNAs/mRNAs in TNM I stage lung adenocarcinoma. Oncotarget. 8(31). 51703–51718. 34 indexed citations
20.
Su, Peng, Yuefeng Zhang, Yong Li, et al.. (2016). Identification of the Key Genes and Pathways in Esophageal Carcinoma. Gastroenterology Research and Practice. 2016. 1–11. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabela W. Cunha Breakdown of academic impact, for papers by Yang Cheng Breakdown of academic impact, for papers by C Meregalli Breakdown of academic impact, for papers by Zixin Guo Breakdown of academic impact, for papers by Masataka Shimonosono Breakdown of academic impact, for papers by Ling‐Yu Chu Breakdown of academic impact, for papers by Xingcheng Wu Breakdown of academic impact, for papers by Annalise Katz‐Summercorn Breakdown of academic impact, for papers by Kunli Du Breakdown of academic impact, for papers by Junhui Fu
Rankless by CCL
2026